Q.Z.O.S v1.0
Q.Z.O.S
Locations

Sector 3: Medical Complex

Critical medical facility and resource depot

SECTOR 3: MEDICAL COMPLEX

Status: 🟑 MODERATE RISK
Type: Medical & Research Facility
Population: ~150 (medical staff + patients)
Infection Density: 25% (estimated)


Overview

Sector 3 houses the Central Hospital Complex, the last functioning medical facility within the quarantine zone. Despite ongoing infection threats, a dedicated team of doctors and nurses continue to operate, treating both infected subjects in early stages and injured personnel.

Facility Map

β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”
β”‚  SECTOR 3 - MEDICAL COMPLEX                         β”‚
β”œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€
β”‚                                                     β”‚
β”‚   [MAIN HOSPITAL BUILDING]                          β”‚
β”‚   β”œβ”€β”€ Emergency Room (Ground Floor)                 β”‚
β”‚   β”œβ”€β”€ Surgery Wing (Floor 2)                        β”‚
β”‚   β”œβ”€β”€ ICU / Isolation Wards (Floor 3)               β”‚
β”‚   β”œβ”€β”€ Research Lab (Floor 4)                        β”‚
β”‚   └── Roof Access (Helipad)                         β”‚
β”‚                                                     β”‚
β”‚   [OUTPATIENT CLINIC]                               β”‚
β”‚   β”œβ”€β”€ Triage Area                                   β”‚
β”‚   β”œβ”€β”€ Examination Rooms (12)                        β”‚
β”‚   └── Pharmacy                                      β”‚
β”‚                                                     β”‚
β”‚   [ADMIN BUILDING]                                  β”‚
β”‚   β”œβ”€β”€ Staff Quarters                                β”‚
β”‚   β”œβ”€β”€ Cafeteria                                     β”‚
β”‚   └── Records Archive                               β”‚
β”‚                                                     β”‚
β”‚   [SUPPLY DEPOT]                                    β”‚
β”‚   β”œβ”€β”€ Medical Supplies Warehouse                    β”‚
β”‚   β”œβ”€β”€ Pharmaceutical Storage (refrigerated)         β”‚
β”‚   └── Equipment Maintenance                         β”‚
β”‚                                                     β”‚
β””β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜

Key Personnel

Medical Director

Dr. Sarah Chen - Infectious Disease Specialist
15 years experience, leading antiviral research program

Chief Surgeon

Dr. Marcus Webb - Trauma Surgeon
Former military medic, specializes in combat injuries

Head Nurse

Elena Volkova, RN - ICU Coordinator
Manages patient care and infection control protocols

Staff Count

  • Doctors: 12
  • Nurses: 28
  • Lab Technicians: 8
  • Support Staff: 15
  • Security: 12

Medical Capabilities

Treatment Services

Emergency Care

  • Trauma surgery (24/7 availability)
  • Blood transfusions
  • Emergency amputations
  • Gunshot/blast wound treatment

Infection Management

  • Stage-1 antiviral treatment
  • Quarantine isolation (20 beds)
  • Pathogen testing & screening
  • Experimental therapy trials

General Medical

  • Broken bone treatment
  • Wound care & sutures
  • Antibiotics distribution
  • Vaccinations

Research Programs

Antiviral Development

Compound-7 Trial - Phase 2 testing
Success rate: 60% (Stage-1 subjects)
Side effects: Moderate

Pathogen Analysis

  • Infection progression studies
  • Mutation tracking
  • Vaccine development (early stage)

Critical Resources

Medical Supplies (Current Stock)

ItemQuantityStatus
Antibiotics3-month supplyβœ… Good
Painkillers2-month supply⚠️ Moderate
Surgical EquipmentFull setβœ… Good
Blood (O-negative)40 units⚠️ Low
IV Fluids500 bagsβœ… Good
Antiviral Compound-725 dosesπŸ”΄ Critical
Trauma Kits80 unitsβœ… Good

Equipment Inventory

  • X-Ray machines: 2 (both functional)
  • CT Scanner: 1 (intermittent power issues)
  • Ventilators: 8 (6 operational)
  • Portable Ultrasound: 4
  • BioScan-7 units: 6
  • Autoclave sterilizers: 3

Threat Assessment

Infected Presence

  • Inside Buildings: Minimal (regular patrols)
  • Perimeter: 15-20 Carriers (Stage-1)
  • Nearby Sectors: 5-8 Shriekers (Stage-2)

Hot Zones

⚠️ Avoid these areas:

  • Basement Morgue: Uncleared, possible infected
  • East Wing (Floor 2): Structural damage, unstable
  • Underground Parking: Dark, limited visibility

Security Measures

  • 24/7 armed security (12 guards)
  • Perimeter fence (3m high, chain-link)
  • Guard stations (4 positions)
  • Emergency lockdown system
  • Backup generator

Access Procedures

For Personnel Seeking Treatment

Step 1: APPROACH
β”œβ”€β”€ Radio ahead on 162.400 MHz
β”œβ”€β”€ Identify self and injury type
└── Await clearance

Step 2: ENTRY SCREENING
β”œβ”€β”€ Thermal scan at gate
β”œβ”€β”€ Visual inspection
└── If clear β†’ proceed
    If infected β†’ quarantine protocol

Step 3: TRIAGE
β”œβ”€β”€ Severity assessment
β”œβ”€β”€ Treatment priority assignment
└── Directed to appropriate ward

Step 4: TREATMENT & RELEASE
β”œβ”€β”€ Medical care provided
β”œβ”€β”€ Resupply (if needed)
└── Departure clearance

For Supply Runs

Best Route: Highway 7 β†’ East Entrance β†’ Supply Depot
Security Escort: Required for large deliveries
Timing: Daytime only (08:00-16:00)

Notable Locations

Research Lab (Floor 4)

Access: Level 3 Clearance Required

Contains:

  • Advanced microscopy equipment
  • Pathogen samples (secured vault)
  • Antiviral synthesis station
  • Data servers (infection tracking)

Isolation Ward (Floor 3)

20-bed quarantine facility for Stage-1 subjects undergoing treatment.

Survival Rate:

  • Day 1-3 post-infection: 85%
  • Day 4-7 post-infection: 60%
  • Day 8+ post-infection: 15%

Pharmacy (Outpatient Clinic)

Stock includes:

  • Antibiotics (various)
  • Pain management drugs
  • Antiviral Compound-7 (limited)
  • Anti-inflammatory meds
  • Emergency epinephrine

Recent Activity

Success Story: Cure Rate

Last 30 Days:

  • Patients treated (infected): 47
  • Successfully cured: 29 (62%)
  • Lost to progression: 18 (38%)
  • Average treatment duration: 8 days

Supply Deliveries

Last 7 Days:

  • Medical supplies: 3 deliveries
  • Food/water: 2 deliveries
  • Ammunition (security): 1 delivery
  • Antiviral Compound: 0 (⚠️ OVERDUE)

Incident Reports

Incident #M3-042

Date: 2026-01-03
Type: Stage-2 breach attempt
Outcome: Repelled, 1 guard injured (non-fatal)

Single Shrieker attempted entry via East Wing hole. Security engaged with M4A1, 14 rounds expended. Specimen eliminated. Recommend sealing structural breach ASAP.
β€” Security Chief Williams

Services Available

For All Personnel

βœ… Emergency medical treatment
βœ… Infection screening
βœ… Basic supplies (bandages, water)
βœ… Short-term shelter (24 hours max)
βœ… Communications access

For Medical Emergencies

βœ… Trauma surgery
βœ… Blood transfusions
βœ… Intensive care
βœ… Antiviral treatment (if eligible)
βœ… Evacuation via helipad

Urgent Needs

Critical Shortages

  1. Antiviral Compound-7 - Only 25 doses remaining
  2. Blood (O-negative) - Below minimum safe level
  3. Diesel Fuel - Generator reserves at 30%
  4. CT Scanner Parts - Needs repair

Requested Support

  • Supply convoy from Checkpoint Alpha
  • Engineering team (structural repairs)
  • Additional security personnel (nights)

Contact Information

Radio Callsign: "MERCY THREE"
Primary Frequency: 162.400 MHz
Emergency Frequency: 156.800 MHz

Helipad Status: OPERATIONAL
Landing Clearance: Contact on approach

Field Notes

Sector 3 is saving lives every day. If you're injured, get to Mercy Three. Dr. Chen's team works miracles with what they have.
β€” Paramedic Log

The medical complex is more than a hospitalβ€”it's hope. Knowing there's a place that can cure the infection keeps people fighting to survive.
β€” Civilian Refugee #4892

Supply situation is dire. If we don't get more Compound-7 soon, we'll have to start turning away Stage-1 subjects. That's a death sentence.
β€” Dr. Sarah Chen, Medical Director